Gene · 6590
Papers3,867
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,867
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Secretory leukocyte protease inhibitor modulates FcεRI-dependent but not Mrgprb2-dependent mastocyte function in psoriasis. | Int Immunopharmacol | 2023 | 37453153 | PubTator, text mining | PubMed |
| CTHRC1 Induces Pancreatic Stellate Cells (PSCs) into Myofibroblast-like Cancer-Associated Fibroblasts (myCAFs). | Cancers (Basel) | 2023 | 37444482 | PubTator, text mining | PubMed |
| Transcriptional Landscape of 3D vs. 2D Ovarian Cancer Cell Models. | Cancers (Basel) | 2023 | 37444459 | PubTator, text mining | PubMed |
| WFDC3 inhibits tumor metastasis by promoting the ERβ-mediated transcriptional repression of TGFBR1 in colorectal cancer. | Cell Death Dis | 2023 | 37443102 | PubTator, text mining | PubMed |
| Spatially resolved multiomics of human cardiac niches. | Nature | 2023 | 37438528 | PubTator, text mining | PubMed |
| Brewers' Spent Grain: An Unprecedented Opportunity to Develop Sustainable Plant-Based Nutrition Ingredients Addressing Global Malnutrition Challenges. | J Agric Food Chem | 2023 | 37428126 | PubTator, text mining | PubMed |
| Is There a Difference in the Proteomic Profile of Stimulated and Unstimulated Saliva Samples from Pregnant Women with/without Obesity and Periodontitis? | Cells | 2023 | 37408223 | PubTator, text mining | PubMed |
| UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma. | Nat Commun | 2023 | 37407562 | PubTator, text mining | PubMed |
| Successful surgical management of an aggressive IgG4-related sclerosing esophageal inflammatory pseudotumor: a case report and review of literature. | J Cardiothorac Surg | 2023 | 37403075 | PubTator, text mining | PubMed |
| Single cell transcriptomics identifies distinct profiles in pediatric acute respiratory distress syndrome. | Nat Commun | 2023 | 37391405 | PubTator, text mining | PubMed |
| Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis. | Acta Derm Venereol | 2023 | 37387475 | PubTator, text mining | PubMed |
| Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in Kenya. | Front Reprod Health | 2023 | 37383290 | PubTator, text mining | PubMed |
| Afterbirth oral fluid secretory leukocyte protease inhibitor decreased in acute histologic chorioamnionitis in preterm birth. | Am J Reprod Immunol | 2023 | 37382168 | PubTator, text mining | PubMed |
| T-helper cells and their cytokines in pathogenesis and treatment of asthma. | Front Immunol | 2023 | 37377958 | PubTator, text mining | PubMed |
| Possible Therapeutic Mechanisms and Future Perspectives of Vaginal Microbiota Transplantation. | Microorganisms | 2023 | 37374929 | PubTator, text mining | PubMed |
| Relationship between Human Papillomavirus Status and the Cervicovaginal Microbiome in Cervical Cancer. | Microorganisms | 2023 | 37374919 | PubTator, text mining | PubMed |
| Toward a Systematic Assessment of Sex Differences in Cystic Fibrosis. | J Pers Med | 2023 | 37373913 | PubTator, text mining | PubMed |
Future Perspective for ALK-Positive Anaplastic Large Cell Lymphoma with Initial Central Nervous System (CNS) Involvement: Could Next-Generation ALK Inhibitors Replace Brain Radiotherapy for the Prevention of Further CNS Relapse? | Pediatr Rep | 2023 | 37368362 | PubTator, text mining | PubMed |
| A Review on Saliva-Based Health Diagnostics: Biomarker Selection and Future Directions. | Biomed Mater Devices | 2023 | 37363139 | PubTator, text mining | PubMed |
| LDL Transcytosis by the Arterial Endothelium-Atherosclerosis by a Thousand Cuts? | Curr Atheroscler Rep | 2023 | 37358804 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6590/papers?page=17